By contrast, in allogeneic settings, the administered cells can recognize healthy recipient’s tissues via TCRs in an MHC molecule-dependent manner, with subsequent induction of apoptosis of healthy cells and GvHD manifestation (37–39). This evidence concerns the gene HLA-C and graft versus host disease.